icon-folder.gif   Conference Reports for NATAP  
 
  64rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Washington, DC Nov 1-5 2013
Back grey_arrow_rt.gif
 
 
 
Daclatasvir Pharmacokinetics in Healthy Subjects: No Clinically Relevant Drug-Drug Interaction With Either Cyclosporine or Tacrolimus
 
 
  Reported by Jules Levin, AASLD 2013 Nov 1-5 Wash DC
 
Bifano M,1 Adamczyk R,1 Hwang C,1 Kandoussi H,2 Marion A,3 Bertz RJ1 1Bristol-Myers Squibb, Hopewell, NJ; 2Bristol-Myers Squibb, Lawrenceville, NJ; 3ICON Development Solutions, Omaha, NE
 
Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C - (11/25/13)
 
Drug-drug interactions with oral anti-HCV agents and Idiosyncratic Hepatotoxicity in the Liver Transplant setting - (11/25/13)

AASLD1.gif

AASLD2.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif